Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.

Título

Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.

Autor

Zerrin Orbak, Fuat Laloglu, Hulya Akat

Descripción

The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up.

Fecha

2021

Materia

covid-19, pneumonia, kawasaki disease

Identificador

10.1017/S1047951120004291

Fuente

Cardiology in the young

Archivos

https://socictopen.socict.org/files/to_import/pdfs/3cc11882eb57e54814340284c6489efa.pdf

Colección

Coronavirus

Citación

Zerrin Orbak, Fuat Laloglu, Hulya Akat, “Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.,” SOCICT Open, consulta 18 de abril de 2026, https://socictopen.socict.org/items/show/4293.

Formatos de Salida

Position: 9436 (26 views)